Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up
- Resource Type
- Article
- Source
- In
Journal of Neuroimmunology 15 October 2015 287:64-70 - Subject
- Language
- ISSN
- 0165-5728